Part II: consensus statements and expert recommendations for BRCA-associated breast cancer in the Asia-Pacific region: clinical management.
Saved in:
| Title: | Part II: consensus statements and expert recommendations for BRCA-associated breast cancer in the Asia-Pacific region: clinical management. |
|---|---|
| Authors: | Park YH; Division of Haematology-Oncology, Department of Medicine, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Lee SC; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore., Singer CF; Department of Obstetrics and Gynaecology, Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria., Balmaña J; Department of Medical Oncology, University Hospital Campus Vall Hebron, Barcelona, Spain., Dent RA; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore., Tan VK; Department of Breast Surgery, Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore., Mulansari NA; Haematology-Medical Oncology Division, Internal Medicine Department, Cipto Mangunkusumo National General Hospital/Universitas Indonesia, Jakarta, Indonesia., Yusof MM; Picaso Cancer Centre, Hospital Picaso, Petaling Jaya, Selangor, Malaysia., Que FVF; Department of Internal Medicine and Oncology, St Luke's Medical Center, Quezon City and Global City, Metro Manila, Philippines., Lu YS; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan., Parinyanitikul N; Medical Oncology Unit, King Chulalongkorn Memorial Hospital, Bangkok, Thailand., Pham CP; The Nuclear Medicine and Oncology Center, Bachmai Hospital, Hanoi, Vietnam.; Nuclear Medicine Department, Hanoi Medical University, Hanoi, Vietnam.; Oncology and Nuclear Medicine Department, University of Medicine and Pharmacy, Vietnam National University, Hanoi, Vietnam., Taib NA; Department of Surgery, Faculty of Medicine, University Malaya, UM Cancer Research Institute, Kuala Lumpur, Malaysia., Kong SY; Department of Laboratory Medicine and Genetic Counselling Clinic, National Cancer Center, Goyang, Gyeonggi-do, Republic of Korea., Antill Y; Familial Cancer Centre, Royal Melbourne Hospital, Melbourne, VIC, Australia.; Faculty of Medicine and Health Sciences, Monash University, Melbourne, VIC, Australia., Kim HJ; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. |
| Source: | Frontiers in oncology [Front Oncol] 2025 Jun 23; Vol. 15, pp. 1507840. Date of Electronic Publication: 2025 Jun 23 (Print Publication: 2025). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2025.1507840 |
